INTRODUCTION
Antimicrobial peptides (AMPs) can be categorized into 4 major classes on the basis of their sequence and structural characteristics: (i) amphipathic α-helical linear peptides, (ii) linear peptides presenting a cyclic moiety formed by a disulphide bond at the C terminus, (iii) β-hairpin peptides stabilized by 2 or more disulphide bridges, and (iv) certain amino acid-rich linear peptides such as Pro, Arg, or Trp. The first class includes several hetero-or homodimeric AMPs such as halocidin (1), distinctin (2), dicynthaurin (3), cathelicidin CAP11 (4), and PMAP-36 (5), consisting of 2 peptide chains linked by a disulphide bond. These molecules do not share any sequence homology. And these dimeric AMPs have shown a broad spectrum of antimicrobial activity, with a remarkable range of effects on Grampositive and Gram-negative bacteria, yeast, and fungi. Considering the position of the disulphide bond, halocidin and dicynthaurin, which are isolated from the hemocytes of the tunicate, Halocynthia aurantium, have a disulphide bond located near the N-terminus and in the central portion of the molecules, respectively. Distinctin from the tree frog Phyllomedusa distincta and cathelicidin CAP 11 from guinea pig neutrophils have a disulphide bond near the C-terminal portion of the molecules. The disulphide bond of PMAP-36 from pig myeloid is positioned at the C-terminus. The salt (NaCl is the predominant salt in vivo) sensitivity of cationic AMPs is a major obstacle in their development as novel therapeutic agents. Although AMPs exhibit significant antibacterial activity in vitro, many peptides seem to lose this activity under physiological salt conditions. Salt sensitivity has been observed in several AMPs, including β-defensins, cecropins, indolicidins, gramicidins, bactenecins, and magainins (6-8). However, not all peptides are salt sensitive, and some peptides show potent salt-insensitive antimicrobial activities (e.g. clavanin, tachyplesins, and polyphemusins) (8, 9). It is possible to develop synthetic α-helical peptides that substantially vary in activity and salt resistance by altering peptide hydrophobicity, amphipathicity, charge, and degree of α-helicity (10). Recent studies have demonstrated that in addition to their antimicrobial activities, several AMPs including human LL-37, rabbit CAP18, sheep SMAP-29, bactenecin, indolicidin, and BMAP-27, have the potential to inhibit lipopolysaccharide (LPS)-induced cellular cytokine and/or nitric oxide (NO) release by directly binding to the LPS or by blocking the binding of LPS to the LPS-binding protein (LBP) (11, 12) . These properties render these peptides attractive drug candidates for the treatment of endotoxin shock and sepsis caused by infection with Gram-negative bacteria.
In the present study, to investigate the effects of the position of the disulphide bond located in homo-dimeric α-helical AMPs on salt resistance and LPS-neutralizing activity, we designed and synthesized an ideal amphipathic α-helical 11-meric model peptide (K6L4W1) composed of 6 lysine molecules, 4 leucine http://bmbreports.org
Peptides
Amino acid sequences The minimal peptide concentration (MHC) that produces 10% hemolysis. When no detectable hemolysis was observed at 400 μg/ml, we used a value of 800 μg/ml to calculate the therapeutic index. The ratio of the MHC (μg/ml) over the geometric mean (GM) of the MIC (μg/ml). Table 2 . Antimicrobial and hemolytic activities and cell selectivity of the designed model antimicrobial peptides molecules, and 1 tryptophan molecule, and its 3 homo-dimeric peptides (di-K6L4W1-N, di-K6L4W1-M and di-K6L4W1-C), with a disulphide bond at the N-terminus, the central position and the C-terminus of the molecules, respectively. The antimicrobial activity and bactericidal kinetics of these newly designed peptides against Gram-positive and Gram-negative bacterial strains were examined in the presence or absence of physiological levels of NaCl. The haemolytic activity of these peptides against human erythrocytes was also examined. Next, we investigated the mode of bactericidal action of the peptides by measuring their potential to cause the leakage of a fluorescent dye from lipid vesicles, the depolarization of the cytoplasmic membrane potential of Staphylococcus aureus. Furthermore, the LPS-neutralizing activity of these peptides was established by examining the inhibition of NO release in LPS-induced mouse macrophage RAW264.7 cells. Taken together, our results will help in designing salt-resistant α-helical homo-dimeric AMPs with potent LPS-neutralizing and antimicrobial activities.
RESULTS AND DISCUSSION

Synthesis of 3 dimeric peptides with a disulphide bond
Each corresponding monomeric peptide (CKLKKLWKKLLK-NH2, KLKKLWCKKLLK-NH2 and KLKKLWKKLLKC-NH2) of the 3 dimeric peptides (di-K6L4W1-N, di-K6L4W1-M, and di-K6L4W1-C) was purified to ＞95% purity by reverse-phase high-performance liquid chromatography (RP-HPLC) on an analytical Vydac C18 column. The 3 homo-dimeric peptides were prepared by oxidation of each of the corresponding monomeric peptides. The oxidation of each monomeric peptide was performed in 10% DMSO solution under oxygen atmosphere for 48 h at room temperature (peptide concentration, 1 mg/ml). The disulphide bond formation of each monomeric peptide while forming the 3 homo-dimeric peptides was monitored by RP-HPLC on an analytical C18 column (data not shown). The final purity of the 3 homo-dimeric peptides, as analyzed by analytical RP-HPLC, was ＞95%. The correct molecular masses of the purified dimeric peptides were confirmed using matrix-assisted laser-desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS) (Shimadzu, Japan) ( Table 1) .
